Caladrius Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Caladrius Biosciences's estimated annual revenue is currently $11.9M per year.
- Caladrius Biosciences's estimated revenue per employee is $155,000
Employee Data
- Caladrius Biosciences has 77 Employees.
- Caladrius Biosciences grew their employee count by 5% last year.
Caladrius Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP R&D and CMO | Reveal Email/Phone |
2 | EVP R&D and CMO | Reveal Email/Phone |
3 | Executive Assistant to the CEO | Reveal Email/Phone |
Caladrius Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.7M | 56 | 2% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $5.7M | 37 | -33% | N/A | N/A |
#4 | $114.8M | 529 | 6% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 83 | -22% | $206.4M | N/A |
#8 | $492.2M | 1834 | -15% | $568M | N/A |
#9 | $1.9M | 12 | 71% | N/A | N/A |
#10 | $4.8M | 31 | 7% | N/A | N/A |
What Is Caladrius Biosciences?
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases.
keywords:N/AN/A
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Caladrius Biosciences News
2022-04-17 - Caladrius Biosciences (NASDAQ:CLBS) Receives New ...
Caladrius Biosciences (NASDAQ:CLBS) Receives New Coverage from Analysts at StockNews.com. Posted by admin on Apr 20th, 2022.
2022-04-13 - Caladrius Biosciences (NASDAQ:CLBS) & Marpai (NASDAQ ...
Caladrius Biosciences (NASDAQ:CLBS) & Marpai (NASDAQ:MRAI) Head-To-Head Comparison. Posted by admin on Apr 15th, 2022.
2022-04-06 - Caladrius Biosciences Treats First Patient in the Phase 1b ...
Caladrius Biosciences Treats First Patient in the Phase 1b Trial of CLBS201 for the Treatment of Diabetic Kidney Disease.
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.7M | 77 | 3% | N/A |
#2 | $14.2M | 79 | 11% | N/A |
#3 | $7.5M | 83 | 15% | N/A |
#4 | $13.7M | 83 | 34% | N/A |
#5 | $18.1M | 86 | N/A | N/A |
